Duncan Jonathan A L, Bond Jeremy S, Mason Tracey, Ludlow Anna, Cridland Peter, O'Kane Sharon, Ferguson Mark W J
Manchester, United Kingdom From Renovo Ltd. and the University of Manchester.
Plast Reconstr Surg. 2006 Sep 15;118(4):909-918. doi: 10.1097/01.prs.0000232378.88776.b0.
The field of scar assessment lacks a standard methodology. Previous methods have focused on a wide range of scar types, resulting in poorer sensitivity and diminishing their discriminatory effectiveness.
As part of a clinical trial investigating the scar-improving efficacy of transforming growth factor-beta3, the authors investigated the use of a visual analogue scale and scar ranking as scar assessment tools. Scar photographic images were assessed using a newly developed computerized scar assessment system by an external lay panel.
A total of 4296 scar images were collected for visual analogue scale assessment and 2148 scar pairs were collected for scar ranking. Intrarater consistency was 100 percent for the ranking data, with differences very close to zero for the visual analogue scale consistency data. Reducing the number of assessors in the external panel significantly improved intraclass correlation coefficients. From month 1 to month 12, the correlation coefficients for the difference in visual analogue scale score showed that the assessors reliably noted the changes in the maturing scars. Combining logistic regression with an area under the curve of 0.72 in a receiver operating characteristic curve analysis, the visual analogue scale score was shown to be a highly statistically significant predictor of a good scar.
The authors have shown the visual analogue scale scar scoring and scar ranking methods to be consistent, reliable, valid, and feasible. These methods for scar assessment are highly sensitive and capable of reliably measuring differences in scar quality, making them valuable techniques, reaching an unmet clinical need, and enabling investigation of changes in scar quality (e.g., with time or after therapeutic intervention).
瘢痕评估领域缺乏标准方法。以往的方法关注多种瘢痕类型,导致敏感性较差且其鉴别有效性降低。
作为一项研究转化生长因子β3改善瘢痕疗效的临床试验的一部分,作者研究了使用视觉模拟评分法和瘢痕分级作为瘢痕评估工具。瘢痕照片图像由外部非专业小组使用新开发的计算机化瘢痕评估系统进行评估。
共收集4296张瘢痕图像用于视觉模拟评分法评估,收集2148对瘢痕用于瘢痕分级。分级数据的评估者内一致性为100%,视觉模拟评分法一致性数据的差异非常接近零。减少外部小组中的评估者数量显著提高了组内相关系数。从第1个月到第12个月,视觉模拟评分法得分差异的相关系数表明评估者能够可靠地记录成熟瘢痕的变化。在受试者工作特征曲线分析中,将逻辑回归与曲线下面积为0.72相结合,结果显示视觉模拟评分法得分是瘢痕良好的高度统计学显著预测指标。
作者已证明视觉模拟评分法瘢痕评分和瘢痕分级方法具有一致性、可靠性、有效性和可行性。这些瘢痕评估方法高度敏感,能够可靠地测量瘢痕质量差异,使其成为有价值的技术,满足了未满足的临床需求,并能够研究瘢痕质量的变化(如随时间或治疗干预后)。